Local view for "http://purl.org/linkedpolitics/eu/plenary/2003-12-17-Speech-3-103"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20031217.4.3-103"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:translated text |
"The Grossetête report on the introduction of a Community code relating to medicinal products for human use is basically intended to protect the interests of the pharmaceutical industry. It is disgusting that it is the big pharmaceutical trusts’ hunger for profit that has the last word in an area in which priority should be given to public health, because protection of the monopoly on patents, which ensures this industry’s profits while sending the prices of medicines soaring, has the drastic effect of denying hundreds of thousands of human beings access to those medicines.
Although we have supported the amendments in favour of better labelling or informing the public about the effects of medicines, we have, on the other hand, voted against the amendments protecting the monopoly of pharmaceutical laboratories.
In our view, public health and the interests of patients are much more important than freedom of trade and shareholders’ profits."@en1
|
Named graphs describing this resource:
The resource appears as object in 2 triples